Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
CSE: ALEN.U — AI Meets Digital Health (click to learn more) What’s Behind Cannabis Stock HERB? (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Silo Pharma Inc SILO

Healthcare Psychedelics
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SILO)

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

GlobeNewswire December 30, 2025

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

GlobeNewswire November 17, 2025

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

GlobeNewswire October 29, 2025

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

GlobeNewswire October 23, 2025

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

GlobeNewswire October 8, 2025

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

GlobeNewswire October 6, 2025

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire October 1, 2025

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire September 30, 2025

Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management

GlobeNewswire September 29, 2025
View More News ››

Opinion & Analysis (NDAQ:SILO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SILO)

RE:SILO.... Ceelo Green? Nope ...SILO Red on NR

Bing Videos
Iseneschal - September 16, 2025

SILO.... Ceelo Green? Nope ...SILO Red on NR

70 cents ish...on over 8 million shares
Iseneschal - September 16, 2025

Silo Pharma Enters into Letter of Intent to Form...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage...
AveragePenny - June 25, 2025

Silo Pharma (NASDAQ:SILO): Pioneering Novel Therapeutics for

Interesting play in the psychedelic therapeutics space. SILO's got some promising pipeline candidates targeting PTSD, Alzheimer's...
MikeTester - January 24, 2025

Buy buddy buy because it's taking off this morning.

So that you guys should be on-board with this stock already.
coolfooldumbguy - January 8, 2025

Silo Pharma, Inc. (NASDAQ:SILO) &#8211; A Promising Developm

http://beyondspx.com/2024/08/02/silo-pharma-inc-nasdaqsilo-a-promising-developmental-stage-biopharmaceutical-company/
MikeTester - August 3, 2024
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp., together with its subsidiaries, engages in the acquisition, exploration, and development of lithium ...
View More »

Podcasts